SCO­TUS de­clines to re­view for­mer In­sys founder John Kapoor's con­vic­tion

The Supreme Court on Mon­day said it will not re­view an ap­peal on rack­e­teer­ing charges by for­mer opi­oid king­pin John Kapoor, who was con­vict­ed in 2019, and again in 2020, for brib­ing doc­tors to sell his com­pa­ny’s fen­tanyl-based pain med­ica­tion.

Kapoor’s In­sys Ther­a­peu­tics, made fa­mous for its bribes and din­ners to en­tice doc­tors to meet pre­scrib­ing quo­tas of the firm’s spray-ver­sion of a pow­er­ful opi­oid, pre­vi­ous­ly paid $225 mil­lion to set­tle gov­ern­ment probes in­to its wrong­do­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER